The human vascular endothelial growth factor ELISA test (human VEGF) quantifies human VEGF in serum, plasma, buffered solution, or human cell culture medium.The assay will only recognize human VEGF.
The human vascular endothelial growth factor ELISA (human VEGF) test quantifies human VEGF in serum, the plasma the buffered solution or the human cell culture medium.The assay will recognize only the natural and recombinant human VEGF.Method principle The ELISA (immuno-enzymatic test) solid phase sandwich for human VEGF is designed to measure the amount of the target bound between a pair of matched antibodies.A target specific antibody was pre-vessed in the wells of the supplied microplate.The samples, standards or controls are then added to these wells and bind to the immobilized antibody (capture).The sandwich is formed by the addition of the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal.The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample.Strict validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, the accuracy and consistency of batch to batch.See the product manual for more information on validation.
VEGF is an important regulator of angiogenesis and vasculogenesis.
Benefit from simplified accuracy
The SCD kit is an immunoenzymatic (ELISA) solid-phase sandwich test. A human VEGF-specific polyclonal antibody was coated on the wells of the microtitration strips supplied. Samples, standards, control samples and unknowns are piped into these wells. During the first incubation, the human VEGF antigen binds to immobilized antibodies (capture). After washing, a biotinylated monoclonal antibody specific to human VEGF is added. During the second incubation, this antibody binds to the immobilized human VEGF captured during the first incubation. Streptavidine-peroxidase (enzyme) is added after washing. It binds to the biotinylated antibody to complete the four-member sandwich. Following a third incubation and washing, a substrate solution, which is used by the bound enzyme to produce colour, is added. The intensity of this coloured product is directly proportional to the concentration of human VEGF in the original sample.
Strict validation
The human ELISA Invitrogen VEGF kit includes all the reagents necessary to perform the assay:
See the product package leaflet for specific information on validation.
Angiogenesis, cell analysis, cell viability, proliferation function &, immunoassays, ready-to-use immunoassay
Ordering information
Shipping conditions: Ambient temperature
- Anti-VEGF biotine detection antibody
- Streptavidin-HRP conjugate
- Stabilized chromogen
- Wash and incubation pads
- Discontinue solution
- Plate covers
- Full protocol. Two standard vials per plate offer the possibility of reconstitute a new vial if the whole plate is not executed once.
Easy-to-use sandwich made of L的ELISA provides...
Easy-to-use sandwich L-ELISA provides results usually in one day with a quick incubation protocol in 4 hours
No night incubation is necessary
No night incubation is necessary
strips with 8 removable pre-coated wells
strips with 8 removable pre-coated wells
96-well strips coated with VEG antibodies...
96-well strips coated with VEG antibodies, thus eliminating the need to coat the plate. The pre-coated wells are supplied in strips of 8 removable wells so that the size of the dosage can be adapted and...
Calibration and diluent for recombinant human VEGF
Calibration and diluent for recombinant human VEGF
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 10150723 |
| Specifications |
| Accession number | P15692 |
| Dose range | 23.4-1500 pg/ml |
| Sensitivity of the dosage | <5 pg/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Serum, Surnatant, Surnatant |
| Target species | Human |
| For use with (application) | Colorimetric detection |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 7422 |
| Gene symbol(s) | MVCD1,VEGF,VPF |
| Incubation time | 4 h |
| Coefficient of inter-dose variation | 8.1% |
| Coefficient of intra-dose variation | 4.7% |
| Contents of kits | 96-well pre-coated plate, Streptavidine HRP, HRP diluent, Wash pad, Chromogen, Stop solution, Adhesive plate covers |
| Marker or dye | HRP |
| Genetic marker | VEGF analysis |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 50 μl; Serum, 50 μl; Supernatant, 50 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h |
Origin and customs
| Manufacturer ref. | KHG0111 |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.